Class III — Low Risk Severity Status: Ongoing Authority: FDA

LIDOLOG KIT

Recalling Firm / Manufacturer: Eugia US LLC (East Windsor, NJ, United States)
FDA Recall Number: D-0552-2026
View FDA Source
Source Authority Disclaimer: This drug recall notice is published by Questo using official enforcement reports issued by the U.S. Food & Drug Administration (FDA). It is provided for informational, academic, and clinical research purposes only. Patients should not discontinue prescribed treatments without consulting their physician or pharmacist.
Product & Identification Information
Brand, active ingredients, NDC codes, and manufacturer details
Brand / Trade Name
LIDOLOG KIT
Generic Name
LIDOCAINE, KENALOG, POVIDONE IODINE
Active Substance(s)
Not provided by source
Administration Route
Epidural
National Drug Code (NDC)
76420-760
Total Quantity Recalled
168,300 vials
Official Reason for Recall
Specific hazard or quality defect cited by the FDA

According to the official FDA enforcement report:

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Full Product Description
Packaging specifications and labeling details

Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02

Enforcement & Regulatory Details
FDA classification, report dates, and initiation authority
Health Hazard Classification
Class III
Current Action Status
Ongoing
FDA Enforcement Report Date
June 10, 2026
Firm Initiation Date
May 18, 2026
FDA Classification Date
May 29, 2026
Initiation Type
Voluntary: Firm initiated
Affected Lots & Batch Numbers
Product codes, lot numbers, and expiration dates
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
Distribution Information
Geographic scope of affected shipments

US Nationwide.

Safety Guidance & Actions
Standard FDA protocol for patients and healthcare providers
Advisory Notice
This Class III recall involves technical or packaging non-conformities that are not expected to cause adverse health consequences. Consult your pharmacist if you have questions.

Official Source Provenance

Verified regulatory citation from U.S. FDA OpenFDA

Primary Data Source: U.S. Food & Drug Administration (FDA) OpenFDA API
Recall Number: D-0552-2026
Questo Retrieval Date: July 31, 2026 14:36 1785508602UTCC
View Official FDA Source

System Notice

Confirm Action